OTHER CANCER
Clinical trials for OTHER CANCER explained in plain language.
Never miss a new study
Get alerted when new OTHER CANCER trials appear
Sign up with your email to follow new studies for OTHER CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
First-of-its-Kind pill targets Cancer's 'Guardian Gene' mutation
Disease control Recruiting nowThis study is testing a new oral drug, PC14586 (rezatapopt), for people with advanced solid tumors that have a specific mutation in a gene called TP53 (Y220C). The main goals are to find a safe and effective dose and to see if the drug can shrink tumors. The trial is enrolling up…
Matched conditions: OTHER CANCER
Phase: PHASE1, PHASE2 • Sponsor: PMV Pharmaceuticals, Inc • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Scientists hunt for hidden genetic causes of rare tumors
Knowledge-focused Recruiting nowThis study aims to discover new genetic causes of rare tumors called pheochromocytomas and paragangliomas. Researchers will analyze DNA from up to 2,000 patients and family members to find genes linked to these tumors. The goal is to improve genetic testing and help guide screeni…
Matched conditions: OTHER CANCER
Sponsor: The University of Texas Health Science Center at San Antonio • Aim: Knowledge-focused
Last updated Apr 03, 2026 14:41 UTC